These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 33675555)
1. N-acylethanolamine-hydrolysing acid amidase: A new potential target to treat paclitaxel-induced neuropathy. Toma W; Caillaud M; Patel NH; Tran TH; Donvito G; Roberts J; Bagdas D; Jackson A; Lichtman A; Gewirtz DA; Makriyannis A; Malamas MS; Imad Damaj M Eur J Pain; 2021 Jul; 25(6):1367-1380. PubMed ID: 33675555 [TBL] [Abstract][Full Text] [Related]
2. Desloratadine ameliorates paclitaxel-induced peripheral neuropathy and hypersensitivity reactions in mice. Lu J; Zhao XJ; Ruan Y; Liu XJ; Di X; Xu R; Wang JY; Qian MY; Jin HM; Li WJ; Shen X Acta Pharmacol Sin; 2024 Oct; 45(10):2061-2076. PubMed ID: 38789495 [TBL] [Abstract][Full Text] [Related]
3. Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models. Sasso O; Moreno-Sanz G; Martucci C; Realini N; Dionisi M; Mengatto L; Duranti A; Tarozzo G; Tarzia G; Mor M; Bertorelli R; Reggiani A; Piomelli D Pain; 2013 Mar; 154(3):350-360. PubMed ID: 23218523 [TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors. Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726 [TBL] [Abstract][Full Text] [Related]
5. Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway. Jin W; Yang L; Yi Z; Fang H; Chen W; Hong Z; Zhang Y; Zhang G; Li L Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32326173 [TBL] [Abstract][Full Text] [Related]
6. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. Solorzano C; Zhu C; Battista N; Astarita G; Lodola A; Rivara S; Mor M; Russo R; Maccarrone M; Antonietti F; Duranti A; Tontini A; Cuzzocrea S; Tarzia G; Piomelli D Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20966-71. PubMed ID: 19926854 [TBL] [Abstract][Full Text] [Related]
7. Targeting Peroxisome Proliferator-Activated Receptor-α (PPAR- α) to reduce paclitaxel-induced peripheral neuropathy. Caillaud M; Patel NH; White A; Wood M; Contreras KM; Toma W; Alkhlaif Y; Roberts JL; Tran TH; Jackson AB; Poklis J; Gewirtz DA; Damaj MI Brain Behav Immun; 2021 Mar; 93():172-185. PubMed ID: 33434562 [TBL] [Abstract][Full Text] [Related]
8. N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis. Zhou P; Xiang L; Yang Y; Wu Y; Hu T; Liu X; Lin F; Xiu Y; Wu K; Lu C; Ren J; Qiu Y; Li Y Pharmacol Res; 2019 Jul; 145():104264. PubMed ID: 31063807 [TBL] [Abstract][Full Text] [Related]
9. N-Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth. Romano B; Pagano E; Iannotti FA; Piscitelli F; Brancaleone V; Lucariello G; Nanì MF; Fiorino F; Sparaco R; Vanacore G; Di Tella F; Cicia D; Lionetti R; Makriyannis A; Malamas M; De Luca M; Aprea G; D'Armiento M; Capasso R; Sbarro B; Venneri T; Di Marzo V; Borrelli F; Izzo AA Br J Pharmacol; 2022 Apr; 179(8):1679-1694. PubMed ID: 34791641 [TBL] [Abstract][Full Text] [Related]
10. A Fenofibrate Diet Prevents Paclitaxel-Induced Peripheral Neuropathy in Mice. Caillaud M; Patel NH; Toma W; White A; Thompson D; Mann J; Tran TH; Roberts JL; Poklis JL; Bigbee JW; Fang X; Gewirtz DA; Damaj MI Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33383736 [TBL] [Abstract][Full Text] [Related]
11. Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α. Yang L; Li L; Chen L; Li Y; Chen H; Li Y; Ji G; Lin D; Liu Z; Qiu Y Sci Rep; 2015 Aug; 5():13565. PubMed ID: 26310614 [TBL] [Abstract][Full Text] [Related]
13. Antinociceptive Profile of ARN19702, (2-Ethylsulfonylphenyl)-[(2S)-4-(6-fluoro-1,3-benzothiazol-2-yl)-2-methylpiperazin-1-yl]methanone, a Novel Orally Active Fotio Y; Sasso O; Ciccocioppo R; Piomelli D J Pharmacol Exp Ther; 2021 Aug; 378(2):70-76. PubMed ID: 33986036 [No Abstract] [Full Text] [Related]
14. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats. Fotio Y; Ciccocioppo R; Piomelli D Psychopharmacology (Berl); 2021 Jan; 238(1):249-258. PubMed ID: 33037452 [TBL] [Abstract][Full Text] [Related]
15. N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis. Pontis S; Palese F; Summa M; Realini N; Lanfranco M; De Mei C; Piomelli D Pharmacol Res; 2020 Oct; 160():105064. PubMed ID: 32634582 [TBL] [Abstract][Full Text] [Related]
16. Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215. Li Y; Zhou P; Chen H; Chen Q; Kuang X; Lu C; Ren J; Qiu Y Pharmacol Res; 2018 Jun; 132():7-14. PubMed ID: 29572189 [TBL] [Abstract][Full Text] [Related]
17. Piomelli D; Scalvini L; Fotio Y; Lodola A; Spadoni G; Tarzia G; Mor M J Med Chem; 2020 Jul; 63(14):7475-7490. PubMed ID: 32191459 [No Abstract] [Full Text] [Related]
18. Sex differences in PD-L1-induced analgesia in paclitaxel-induced peripheral neuropathy mice depend on TRPV1-based inhibition of CGRP. Cao Y; Jiang W; Yan F; Pan Y; Gei L; Lu S; Chen X; Huang Y; Yan Y; Feng Y; Li Q; Zeng W; Xing W; Chen D CNS Neurosci Ther; 2024 Jul; 30(7):e14829. PubMed ID: 38961264 [TBL] [Abstract][Full Text] [Related]
19. NAAA inhibitor F96 attenuates BBB disruption and secondary injury after traumatic brain injury (TBI). Li Y; Zhou P; Hu T; Ren J; Xu Y; Qiu Y; Lu C; Li Y Eur J Pharmacol; 2021 Dec; 912():174561. PubMed ID: 34655598 [TBL] [Abstract][Full Text] [Related]